Symbol not found
Stock Predictions, Articles, and News
- From the Web
From Analyst Ratings
BTIG analyst Ryan Zimmerman maintained a Buy rating on Organogenesis Holdings (ORGO – Research Report) today and set a price target of $8.00. The company’s shares closed last Thursday at $3.66. According to TipRanks.com, Zimmerman is a 5-star analyst with an average return of 13.8% and a 57.1% success rate. Zimmerman covers the Healthcare sector,
From Seeking Alpha
China Finance Online (NASDAQ:JRJC) +148% on agreement with Dow Jones.Capitala Finance (NASDAQ:CPTA) +53% announces portfolio activity.Immutep (NASDAQ:IMMP) +52% on announcing United States patent grant for IMP701 antibody.NextDecade (NASDAQ:NEXT) +50% as Rio Grande LNG to cut costs by using five trains, not six.Sphere 3D (NASDAQ:ANY) +45%.Can-Fite BioPharma (NYSEMKT:CANF) +39% on advancing piclidenoson in COVID-19.ReWalk Robotics (NASDAQ:RWLK) +30% on announcing the Centers for Medicare and Medicaid Services issued Healthcare Common Procedure Coding System Level II Code K1007 in response to the application.VBI Vaccines (NASDAQ:VBIV) +19%.Organogenesis (NASDAQ:ORGO) +19% on Q2 preliminary revenue.Moderna (NASDAQ:MRNA) +17% as coronavirus vaccine induces immune response, phase 1 results show.ATIF Holdings (NASDAQ:ATIF) +16%.Everi Holdings (NYSE:EVRI) +14%.China Natural Resources (NASDAQ:CHNR) +12%.Dave & Buster's Entertainment (NASDAQ:PLAY) +12%.RTI Surgical Holdings (NASDAQ:RTIX) +11%.Wipro (NYSE:WIT) +11%.TherapeuticsMD (NASDAQ:TXMD) +10% expands access to AnnoveraInfosys (NYSE:INFY) +10% on Q1 results.Lion Financial (NASDAQ:LGHL) +10%.Jiayin (NASDAQ:JFIN) +9%.Gol Linhas Aereas Inteligentes S.A.